未登录

N

Ning Luan

Chinese Academy of Medical Sciences and Peking Union Medical College

H指数:13

被引数:588

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A QS21+ CpG-Adjuvanted Inactivated Vaccine Elicits Superior Humoral and Moderate Cellular Immunity

QS21+CpG佐剂灭活疫苗诱导出更优的体液免疫和适度的细胞免疫

Journal of Medical Virology

IF4.6

2026-10-280

PRE

Adjuvant Mucosal Strategies Confer Safe and Effective Immunity Against Mycoplasma pneumoniae and Overcome Vaccine-Associated Enhanced Lung Pathology

黏膜佐剂策略可安全有效地诱导对Mycoplasma pneumoniae的免疫力，并克服疫苗相关的增强性肺部病理变化。

Vaccines 2025, Vol. 13, Page 968

IF3.4

2025-09-290

OAAI

A Comparative Study on Immune Protection Efficacy: An HSV-1 Trivalent Antigen Subunit Vaccine Formulated with a Cellular Immunity-Inducing Adjuvant Versus an mRNA Vaccine

关于免疫保护效力的比较研究：一种与细胞免疫诱导佐剂配伍的HSV-1三价抗原亚单位疫苗与mRNA疫苗的比较

Vaccines 2025, Vol. 13, Page 958

IF3.4

2025-09-100

OA

A QS21+ CpG-Adjuvanted Rabies Virus G Subunit Vaccine Elicits Superior Humoral and Moderate Cellular Immunity

一种QS21+CpG佐剂狂犬病病毒G亚单位疫苗可诱导出更优的体液免疫和适度的细胞免疫

Vaccines 2025, Vol. 13, Page 887

IF3.4

2025-08-220

PRE

A QS21

IF3.4

2025-05-060

OA

Herpes simplex virus 1 fusion glycoprotein B H516P prefusion mutation had no effect on vaccine immunogenicity

单纯疱疹病毒1型融合糖蛋白B H516P前融合突变对疫苗免疫原性无影响

IF3.5

2025-05-010

PRE

Immunogenicity Evaluation of Combination Respiratory Syncytial Virus and Varicella-Zoster Virus mRNA Vaccines in C57BL/6J Mice

C57BL/6J小鼠中联合呼吸道合胞病毒和带状疱疹病毒mRNA疫苗的免疫原性评价

IF3.4

2025-03-280

OA

Effects of Rotavirus NSP4 on the Immune Response and Protection of Rotavirus-Norovirus Recombinant Subunit Vaccines in Different Immune Pathways

IF3.4

2024-09-080

OAAI

Evaluation of the Immunological Efficacy of an LNP-mRNA Vaccine Prepared from Varicella Zoster Virus Glycoprotein gE with a Double-Mutated Carboxyl Terminus in Different Untranslated Regions in Mice

IF3.4

2023-09-114

OAAI

A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases

IF10.8

2023-09-014

OAAI

Comparison of Immune Responses between Inactivated and mRNA SARS-CoV-2 Vaccines Used for a Booster Dose in Mice

IF3.5

2023-06-111

OAAI

Comparison of the Immune Effects of an mRNA Vaccine and a Subunit Vaccine against Herpes Zoster Administered by Different Injection Methods

不同注射方法对带状疱疹mRNA疫苗和亚单位疫苗的免疫效果比较

IF3.4

2023-05-203

OAAI

A novel LINC00943/miR-671-5p/ELAVL1 ceRNA crosstalk regulates MPP+ toxicity in SK-N-SH cells

METABOLIC BRAIN DISEASE

IF3.5

2022-07-026

PRE

Role of LL-37 in thrombotic complications in patients with COVID-19

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2022-05-2117

OAAI

Evaluation of a bivalent recombinant vaccine candidate targeting norovirus and rotavirus: Antibodies to rotavirus NSP4 exert antidiarrheal effects without virus neutralization

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2022-05-065

PRE

Ionizable Lipid Nanoparticles Enhanced the Synergistic Adjuvant Effect of CpG ODNs and QS21 in a Varicella Zoster Virus Glycoprotein E Subunit Vaccine

IF5.5

2022-04-307

OAAI

Th2-Oriented Immune Serum After SARS-CoV-2 Vaccination Does Not Enhance Infection In Vitro

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-04-086

OAAI

Comparison of immune responses induced by two or three doses of an alum-adjuvanted inactivated SARS-CoV-2 vaccine in mice

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2022-02-086

OA

Effects of Varicella-Zoster Virus Glycoprotein E Carboxyl-Terminal Mutation on mRNA Vaccine Efficacy

水痘病毒糖蛋白E羧基末端突变对mRNA疫苗效力的影响

IF3.4

2021-12-0711

OAAI

Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models

EMERGING MICROBES & INFECTIONS

IF7.5

2021-11-219

OAAI